Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
Clinical trial NCT02453711 · COMPLETED
Trial details
- NCT number
- NCT02453711
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-03-30
- Enrollment
- 957
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.